Publications by authors named "Goro Doi"

Claim this Profile
S
Successful control of recurrent MAS by canakinumab in a Sjögren syndrome patient with homozygous MEFV P369S variants and review of literatures.
Nobuyuki Ono, Motoki Yoshimura, Toshiya Nishida, Yusuke Yamauchi, Goro Doi

Mod Rheumatol Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Masahiro Ayano, Naoyasu Ueda, Koji Mishima, Shun-Ichiro Ota, Kazuo Kushimoto, Goro Doi

Joint Bone Spine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic targeting of Cas9 nickase expands tandem gene arrays.
Hiroaki Takesue, Satoshi Okada, Goro Doi, Yuki Sugiyama, Emiko Kusumoto

Cell Genom· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Masahiro Ayano, Naoyasu Ueda, Koji Mishima, Shun-Ichiro Ota, Kazuo Kushimoto, Goro Doi

Mod Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Yoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, Sho Fukui, Yuya Fujita, Goro Doi

Mod Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, Takuya Sawabe, Kensuke Irino, Goro Doi

Rheumatology (Oxford)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple-to-use CRISPR-SpCas9/SaCas9/AsCas12a vector series for genome editing in Saccharomyces cerevisiae.
Satoshi Okada, Goro Doi, Shitomi Nakagawa, Emiko Kusumoto, Takashi Ito

G3 (Bethesda)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytically inactive Cas9 impairs DNA replication fork progression to induce focal genomic instability.
Goro Doi, Satoshi Okada, Takehiro Yasukawa, Yuki Sugiyama, Siqin Bala

Nucleic Acids Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report.
Kotoe Takayoshi, Goro Doi, Nobuhiro Tsuruta, Tomoyasu Yoshihiro, Kenta Nio

Medicine (Baltimore)· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis